Lefitolimod + Yervoy clinical trial estimate: Primary completion of P1 trial (NCT02668770) for advanced solid malignancies in Q2 2021 (SVB Leerink) - Jan 9, 2021 - A subscription to REFINITIV is required to gain full access to document 90832192| Page no: 50| REPORT TITLE: "Bringing some TLC to TLR with ImmunoTACs; Initiating coverage with an OP rating"| AUTHOR: Daina Graybosch, et al| DATE: 12/29/20
Trial primary completion date • Oncology • Solid Tumor
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact [email protected].
|